Solvay Shares Mark the Strongest Rise in the SBF 120 at Mid-Session
The Belgian chemical company stands out sharply at mid-session on the Paris market, going against the trend of a declining European market. The stock benefits from a tone change by a German broker, while the broader index declines.
Deutsche Bank Raises Target and Upgrades to Hold, Stock Leads SBF 120
Solvay's stock is up 2.33% at €26.36, marking the strongest rise in the SBF 120 while the index is down 0.71%. This movement coincides with the revision published this Wednesday by Deutsche Bank, which upgraded its recommendation from 'sell' to 'hold' and increased its price target from €23.50 to €26.00. The new target remains slightly below the current price, but the removal of the selling advice relieves downward pressure that weighed on the stock. The stock thus recovers part of the 2.44% decline it suffered on Monday, which had placed it among the index's largest drops. This rebound occurs as rare earths remain a strategic focus highlighted in early June, with the memorandum of understanding signed with Viridis Mining and Minerals to secure a supply starting from 2028.
Stock Moves Above Its 20-Day Moving Average but Still Struggles with Longer Averages
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
With this gain, Solvay moves above its 20-day moving average (€26.11) by nearly 1%. However, the stock remains below its 50-day moving average (€26.86, a -1.86% gap) and its 200-day moving average (€26.93, a -2.12% gap), which form a tight technical resistance zone around €27. The RSI at 42 moves out of the lower zone without indicating any particular tension, and the MACD histogram slightly re-enters positive territory (+0.02). The performance remains modest over a year (-8.66%), but the stock becomes nearly stable over a month (+0.30%). A sustained crossing of the 50-day moving average (€26.86) and the 200-day moving average (€26.93), located around €26.90, would constitute the next technical milestone to watch in the case.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.